{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:44Z","timestamp":1791823724590,"version":"4.3.4"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72122001"],"award-info":[{"award-number":["72122001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiph.2025.102654","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:21:04Z","timestamp":1736058064000},"page":"102654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiovascular disease and its risk factors among people living with HIV: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"given":"Min","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1938-9365","authenticated-orcid":false,"given":"Jue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.102654_bib1","unstructured":"World Health Statistics. Data on the size of the HIV\/AIDS epidemic \u3008https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/data-on-the-size-of-the-hiv-aids-epidemic?lang=en\u3009. [accessed from November 29, 2024]."},{"key":"10.1016\/j.jiph.2025.102654_bib2","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jiph.2025.102654_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102654_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCULATIONAHA.117.032647","article-title":"Association of human immunodeficiency virus infection and risk of peripheral artery disease","volume":"138","author":"Beckman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jiph.2025.102654_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jiph.2025.102654_bib6","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2025.102654_bib7","unstructured":"WellsGA S., O.\u2032ConnellD, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. \u3008https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\u3009. [accessed from September 20, 2023]."},{"key":"10.1016\/j.jiph.2025.102654_bib8","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2025.102654_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.20982\/tqmp.12.3.p154","article-title":"Fitting three-level meta-analytic models in R: a step-by-step tutorial","volume":"12","author":"Assink","year":"2016","journal-title":"Quant Methods Psychol"},{"key":"10.1016\/j.jiph.2025.102654_bib10","article-title":"Modifiable risk factors for diphtheria: a systematic review and meta-analysis","volume":"5","author":"Ikejezie","year":"2023","journal-title":"Glob Epidemiol"},{"key":"10.1016\/j.jiph.2025.102654_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2025.102654_bib12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jiph.2025.102654_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/09540121.2022.2029820","article-title":"Association of cardio-ankle vascular index and future major adverse cardiovascular events in older adults living with HIV","volume":"35","author":"Rerkasem","year":"2023","journal-title":"AIDS Care"},{"key":"10.1016\/j.jiph.2025.102654_bib14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/cid\/ciy1101","article-title":"Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease, and diabetes among aging adults with human immunodeficiency virus","volume":"69","author":"Kelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciac939","article-title":"Decrease in CD4 T-cell count and risk of severe morbid conditions in people with human immunodeficiency virus infection with controlled viral load after initiating combination antiretroviral therapy between 2006 and 2018","volume":"76","author":"Choufany","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cid\/ciu261","article-title":"Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients","volume":"59","author":"Ingle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","article-title":"Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America","volume":"29","author":"Helleberg","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","author":"Gill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-1293.2005.00265.x","article-title":"Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients","volume":"6","author":"Iloeje","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib20","article-title":"Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study","volume":"10","author":"Mart\u00edn-Iguacel","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jiph.2025.102654_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002424","article-title":"Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: a prospective analysis of the D:A:D observational study","volume":"14","author":"Boyd","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiph.2025.102654_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hiv.12294","article-title":"Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study","volume":"17","author":"Achhra","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/QAI.0000000000002603","article-title":"Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D:A:D study","volume":"86","author":"Petoumenos","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","article-title":"Cardio- and cerebrovascular events in HIV-infected persons","volume":"18","author":"d'Arminio","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/QAD.0000000000003240","article-title":"Associations between HIV viremia during antiretroviral therapy and cardiovascular disease","volume":"36","author":"Elvstam","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib27","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32833b1b26","article-title":"Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients","volume":"24","author":"Achhra","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jiy442","article-title":"The effect of interrupted\/deferred antiretroviral therapy on disease risk: a SMART and START combined analysis","volume":"219","author":"Borges","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib29","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jiph.2025.102654_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/jiw173","article-title":"Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer during HIV Infection","volume":"214","author":"Borges AH","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/01.aids.0000247115.81832.a1","article-title":"Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use","volume":"20","author":"Kwong","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/QAD.0000000000002876","article-title":"Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015","volume":"35","author":"Davy-Mendez","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib33","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/QAD.0000000000001594","article-title":"Cardiovascular outcomes among HIV-infected veterans receiving atazanavir","volume":"31","author":"LaFleur","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12879-021-05787-4","article-title":"Consistent use of lipid lowering therapy in HIV infection is associated with low mortality","volume":"21","author":"Drechsler","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib35","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1007\/s10461-021-03327-4","article-title":"Association of syndemic unhealthy alcohol use, smoking, and depressive symptoms on incident cardiovascular disease among veterans with and without hiv-infection","volume":"25","author":"Chichetto","year":"2021","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jiph.2025.102654_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/QAI.0000000000001981","article-title":"Insomnia as an independent predictor of incident cardiovascular disease in HIV: data from the veterans aging cohort study","volume":"81","author":"Polanka","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2025.102654_bib38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/QAD.0b013e328347fa16","article-title":"Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons","volume":"25","author":"Choi","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1468-1293.2009.00815.x","article-title":"Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients","volume":"11","author":"Bedimo","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jiph.2025.102654_bib41","doi-asserted-by":"crossref","unstructured":"Bozzette S.A., Ake C.E., Tam H.K., Phippard A., Cohen D., Scharstein D.O., Louis T.A. Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 008;47:338-341. \u300810.1097\/QAI.0b013e31815e7251\u3009.","DOI":"10.1097\/QAI.0b013e31815e7251"},{"key":"10.1016\/j.jiph.2025.102654_bib42","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2022.08.756","article-title":"Circulating T cells and cardiovascular risk in people with and without HIV Infection","volume":"80","author":"Kundu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jiph.2025.102654_bib43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/QAI.0000000000003094","article-title":"CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: the Swiss HIV cohort study","volume":"91","author":"Chammartin","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0000000000000662","article-title":"Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV cohort study","volume":"69","author":"Young","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study","volume":"53","author":"Hasse","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab032","article-title":"Association of incomplete adherence to antiretroviral therapy with cardiovascular events and mortality in virologically suppressed persons with HIV: the Swiss HIV cohort study","volume":"8","author":"Castillo-Mancilla","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3894-6","article-title":"Severe infection increases cardiovascular risk among HIV-infected individuals","volume":"19","author":"Mesquita","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12879-016-1735-4","article-title":"Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study","volume":"16","author":"Diaz","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2147\/DDDT.S180981","article-title":"Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study","volume":"13","author":"Antinori","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jiph.2025.102654_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+\u2009count and risk of non-AIDS diseases following initial treatment for HIV infection","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124252","article-title":"Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy","volume":"10","author":"Bandera","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2025.102654_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/hiv.12687","article-title":"Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD)","volume":"20","author":"Bijker","year":"2019","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib53","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/tmi.13405","article-title":"Cardiovascular disease among people living with HIV in Brazil","volume":"25","author":"Boettiger","year":"2020","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jiph.2025.102654_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/hiv.13018","article-title":"Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV","volume":"22","author":"Bogorodskaya","year":"2021","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/cid\/civ316","article-title":"Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population","volume":"61","author":"Desai","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12879-017-2808-8","article-title":"Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study","volume":"17","author":"Dorjee","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib57","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/09540121.2019.1698705","article-title":"U.S. Hospitalization rates and reasons stratified by age among persons with HIV 2014-15","volume":"32","author":"Fleming","year":"2020","journal-title":"AIDS Care"},{"key":"10.1016\/j.jiph.2025.102654_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCOUTCOMES.110.957415","article-title":"The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C","volume":"4","author":"Freiberg","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jiph.2025.102654_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3851\/IMP2724","article-title":"Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals","volume":"19","author":"Gillis","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jiph.2025.102654_bib60","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1093\/cid\/ciaa1878","article-title":"Clinical outcomes of 2-drug regimens vs 3-drug regimens in antiretroviral treatment-experienced people living with human immunodeficiency virus","volume":"73","author":"Greenberg","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4+\u2009T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib62","article-title":"The association of HIV-specific risk factors with cardiovascular events in addition to traditional risk factors in people living with HIV","author":"Mavarani","year":"2023","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jiph.2025.102654_bib63","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000003537","article-title":"Risk of Adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study","author":"Krishnan","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/QAI.0000000000002161","article-title":"Association of HIV infection and antiretroviral therapy with sudden cardiac death","volume":"82","author":"Yen","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1310\/hct1306-343","article-title":"Renal impairment is associated with coronary heart disease in HIV-positive men","volume":"13","author":"Campbell","year":"2012","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jiph.2025.102654_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001155","article-title":"Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy","volume":"2","author":"Carrieri","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiph.2025.102654_bib67","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0000000000001005","article-title":"CD4+\u2009\/CD8+\u2009ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy","volume":"30","author":"Castilho","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252180","article-title":"Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: case of Zimbabwe\u2019s Chitungwiza Central Hospital\u2014a retrospective cohort study (2010\u20132019)","volume":"16","author":"Cheza","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2025.102654_bib69","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12879-017-2510-x","article-title":"Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study","volume":"17","author":"De Socio","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvh.12447","article-title":"Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients","volume":"23","author":"Fernandez-Montero","year":"2016","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jiph.2025.102654_bib71","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/aid.2012.0367","article-title":"Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells\/mm3","volume":"29","author":"Lucero","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jiph.2025.102654_bib72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/QAI.0b013e31817bebb3","article-title":"Poor initial CD4+\u2009recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases","volume":"48","author":"Baker","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154900","article-title":"Neutrophil to lymphocyte ratio and cardiovascular disease incidence in HIV-infected patients: a population-based cohort study","volume":"11","author":"Quiros-Roldan","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.jiph.2025.102654_bib74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/QAI.0000000000002910","article-title":"Insomnia and risk of myocardial infarction among people with HIV","volume":"90","author":"Luu","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cit652","article-title":"Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans","volume":"58","author":"Armah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/aje\/kwz236","article-title":"Association between chronic Hepatitis C virus infection and myocardial infarction among people living with HIV in the United States","volume":"189","author":"Williams-Nguyen","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiph.2025.102654_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12981-021-00383-7","article-title":"Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States","volume":"18","author":"Dorjee","year":"2021","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jiph.2025.102654_bib78","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/EDE.0000000000000041","article-title":"Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients","volume":"25","author":"Brouwer","year":"2014","journal-title":"Epidemiology"},{"key":"10.1016\/j.jiph.2025.102654_bib79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1468-1293.2009.00751.x","article-title":"Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study","volume":"11","author":"Obel","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2025.102654_bib80","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamacardio.2016.2716","article-title":"Association between depressive disorders and incident acute myocardial infarction in human immunodeficiency virus-infected adults: veterans aging cohort study","volume":"1","author":"Khambaty","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jiph.2025.102654_bib81","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s15010-012-0293-y","article-title":"Causes of death among Danish HIV patients compared with population controls in the period 1995-2008","volume":"40","author":"Helleberg","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.jiph.2025.102654_bib82","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0000000000001799","article-title":"Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS clinical trials group longitudinal linked randomized trials cohort","volume":"32","author":"Chow","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib83","article-title":"Incidence of strokes in HIV-positive patients treated with long term antiretroviral treatment","volume":"24","author":"Mapoure","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jiph.2025.102654_bib84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jiph.2025.102654_bib85","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad033","article-title":"Leukocyte count and coronary artery disease events in people with human immunodeficiency virus: a longitudinal study","author":"Avery","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040523","article-title":"Development and validation of the HIV-CARDIO-PREDICT score to estimate the risk of cardiovascular events in HIV-infected patients","volume":"12","author":"Karanika","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jiph.2025.102654_bib87","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0000000000000881","article-title":"Use of abacavir and risk of cardiovascular disease among HIV-infected individuals","volume":"71","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/QAI.0b013e31819ff0e6","article-title":"Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects","volume":"51","author":"Brothers","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw061","article-title":"Risk of cardiovascular events among patients initiating efavirenz-containing versus efavirenz-free antiretroviral regimens","volume":"3","author":"Rosenblatt","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib90","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e31824476e1","article-title":"Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort study","volume":"60","author":"Bucher","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2025.102654_bib91","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/QAD.0b013e3283359253","article-title":"Kidney function and the risk of cardiovascular events in HIV-1-infected patients","volume":"24","author":"George","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2025.102654_bib92","doi-asserted-by":"crossref","DOI":"10.1071\/SH23043","article-title":"Factors associated with the development of coronary artery disease in people with HIV","author":"Mushin","year":"2023","journal-title":"Sex Health"},{"key":"10.1016\/j.jiph.2025.102654_bib93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"Amini","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jiph.2025.102654_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1953","article-title":"A systematic review of the associations between HIV\/HCV coinfection and biomarkers of cardiovascular disease","volume":"28","author":"Osibogun","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jiph.2025.102654_bib95","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/cid\/ciz601","article-title":"Clinical outcomes in persons coinfected with human immunodeficiency virus and Hepatitis C virus: impact of Hepatitis C virus treatment","volume":"70","author":"Mocroft","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib96","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1093\/cid\/ciaa1014","article-title":"Atherosclerotic cardiovascular events in patients infected with human immunodeficiency virus and Hepatitis C virus","volume":"72","author":"Tan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102654_bib97","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2018.11.022","article-title":"irect-acting antiviral therapy for HCV infection is associated with a reduced risk of cardiovascular disease events","volume":"156","author":"Butt","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiph.2025.102654_bib98","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240031593\u3009. [accessed from November 29, 2024]."}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:54:25Z","timestamp":1738673665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1876034125000036"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102654","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease and its risk factors among people living with HIV: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102654"}}